Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2020 Nov 10

PMID 33167496

Citations 291

Authors

Emmanuel Alakunle

Ugo Moens

Godwin Nchinda

Malachy Ifeanyi Okeke

Affiliations

Soon will be listed here.

Abstract

Monkeypox is a zoonotic disease caused by monkeypox virus (MPXV), which is a member of orthopoxvirus genus. The reemergence of MPXV in 2017 (at Bayelsa state) after 39 years of no reported case in Nigeria, and the export of travelers' monkeypox (MPX) from Nigeria to other parts of the world, in 2018 and 2019, respectively, have raised concern that MPXV may have emerged to occupy the ecological and immunological niche vacated by smallpox virus. This review X-rays the current state of knowledge pertaining the infection biology, epidemiology, and evolution of MPXV in Nigeria and worldwide, especially with regard to the human, cellular, and viral factors that modulate the virus transmission dynamics, infection, and its maintenance in nature. This paper also elucidates the role of recombination, gene loss and gene gain in MPXV evolution, chronicles the role of signaling in MPXV infection, and reviews the current therapeutic options available for the treatment and prevention of MPX. Additionally, genome-wide phylogenetic analysis was undertaken, and we show that MPXV isolates from recent 2017 outbreak in Nigeria were monophyletic with the isolate exported to Israel from Nigeria but do not share the most recent common ancestor with isolates obtained from earlier outbreaks, in 1971 and 1978, respectively. Finally, the review highlighted gaps in knowledge particularly the non-identification of a definitive reservoir host animal for MPXV and proposed future research endeavors to address the unresolved questions.

Citing Articles

Advances and challenges of mpox detection technology.

Liu W, Zhang E, Li W, Lv R, Lin Y, Xu Y Biosaf Health. 2025; 6(5):260-269.

PMID: 40078738 PMC: 11895016. DOI: 10.1016/j.bsheal.2024.09.005.

Cases of high-consequence infectious diseases identified in the UK, 1962-2023.

Atkinson B, Beadsworth M, Dunning J J Med Microbiol. 2025; 74(3).

PMID: 40071494 PMC: 11903645. DOI: 10.1099/jmm.0.001982.

A review of epidemiology, diagnosis, and management of Mpox: The role of One Health.

Huang C, Su S, Chen K Glob Health Med. 2025; 7(1):1-12.

PMID: 40026855 PMC: 11866911. DOI: 10.35772/ghm.2024.01072.

MRpoxNet: An enhanced deep learning approach for early detection of monkeypox using modified ResNet50.

Vandana , Sharma C, Shah M Digit Health. 2025; 11:20552076251320726.

PMID: 40013075 PMC: 11863262. DOI: 10.1177/20552076251320726.

Epidemiology, Pathogenesis, and Treatment Options of Monkeypox: A Narrative Review.

Mishra P, Singh R, Patil A Cureus. 2025; 17(1):e77892.

PMID: 39996203 PMC: 11848695. DOI: 10.7759/cureus.77892.

References

Estep R, Messaoudi I, OConnor M, Li H, Sprague J, Barron A . Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection. J Virol. 2011; 85(18):9527-42. PMC: 3165757. DOI: 10.1128/JVI.00199-11. View

Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y . Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019; 19(8):872-879. PMC: 9628943. DOI: 10.1016/S1473-3099(19)30294-4. View

Ogoina D, Iroezindu M, James H, Oladokun R, Yinka-Ogunleye A, Wakama P . Clinical Course and Outcome of Human Monkeypox in Nigeria. Clin Infect Dis. 2020; 71(8):e210-e214. DOI: 10.1093/cid/ciaa143. View

Meiser A, Sancho C, Krijnse Locker J . Plasma membrane budding as an alternative release mechanism of the extracellular enveloped form of vaccinia virus from HeLa cells. J Virol. 2003; 77(18):9931-42. PMC: 224582. DOI: 10.1128/jvi.77.18.9931-9942.2003. View

Hammarlund E, Lewis M, Carter S, Amanna I, Hansen S, Strelow L . Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med. 2005; 11(9):1005-11. DOI: 10.1038/nm1273. View

Song H, Josleyn N, Janosko K, Skinner J, Reeves R, Cohen M . Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions. PLoS One. 2013; 8(10):e77804. PMC: 3798392. DOI: 10.1371/journal.pone.0077804. View

Kumar S, Stecher G, Li M, Knyaz C, Tamura K . MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol. 2018; 35(6):1547-1549. PMC: 5967553. DOI: 10.1093/molbev/msy096. View

McCollum A, Damon I . Human monkeypox. Clin Infect Dis. 2013; 58(2):260-7. DOI: 10.1093/cid/cit703. View

Pickett B, Sadat E, Zhang Y, Noronha J, Squires R, Hunt V . ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 2011; 40(Database issue):D593-8. PMC: 3245011. DOI: 10.1093/nar/gkr859. View

10.

Sale T, Melski J, Stratman E . Monkeypox: an epidemiologic and clinical comparison of African and US disease. J Am Acad Dermatol. 2006; 55(3):478-81. PMC: 9629018. DOI: 10.1016/j.jaad.2006.05.061. View

11.

Nakazawa Y, Mauldin M, Emerson G, Reynolds M, Lash R, Gao J . A phylogeographic investigation of African monkeypox. Viruses. 2015; 7(4):2168-84. PMC: 4411695. DOI: 10.3390/v7042168. View

12.

Hughes A, Irausquin S, Friedman R . The evolutionary biology of poxviruses. Infect Genet Evol. 2009; 10(1):50-9. PMC: 2818276. DOI: 10.1016/j.meegid.2009.10.001. View

13.

Greber U . Signalling in viral entry. Cell Mol Life Sci. 2002; 59(4):608-26. PMC: 11337557. DOI: 10.1007/s00018-002-8453-3. View

14.

Baker R, Bray M, Huggins J . Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003; 57(1-2):13-23. PMC: 9533837. DOI: 10.1016/s0166-3542(02)00196-1. View

15.

Rubins K, Hensley L, Relman D, Brown P . Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus. PLoS One. 2011; 6(1):e15615. PMC: 3022624. DOI: 10.1371/journal.pone.0015615. View

16.

Gruber C, Giombini E, Selleri M, Tausch S, Andrusch A, Tyshaieva A . Whole Genome Characterization of (OPV) Abatino, a Zoonotic Virus Representing a Putative Novel Clade of Old World Orthopoxviruses. Viruses. 2018; 10(10). PMC: 6212904. DOI: 10.3390/v10100546. View

17.

Schultz D, Sagartz J, Huso D, Buller R . Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus. Virology. 2008; 383(1):86-92. PMC: 2630398. DOI: 10.1016/j.virol.2008.09.025. View

18.

Heymann D, Szczeniowski M, Esteves K . Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull. 1999; 54(3):693-702. DOI: 10.1093/oxfordjournals.bmb.a011720. View

19.

Vaughan A, Aarons E, Astbury J, Brooks T, Chand M, Flegg P . Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018. Emerg Infect Dis. 2020; 26(4):782-785. PMC: 7101111. DOI: 10.3201/eid2604.191164. View

20.

Noyce R, Evans D . Synthetic horsepox viruses and the continuing debate about dual use research. PLoS Pathog. 2018; 14(10):e1007025. PMC: 6171955. DOI: 10.1371/journal.ppat.1007025. View